HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Butylparaben Toxicity Testing Recommended By NTP Board

This article was originally published in The Rose Sheet

Executive Summary

The National Toxicology Program Board of Scientific Counselors recommended that toxicity testing be conducted on butylparaben due to the cosmetic preservative's widespread exposure to humans through personal care products, foods and pharmaceuticals

You may also be interested in...



Parabens Tentative Amended Final Report Issued By CIR

The Cosmetic Ingredient Review Expert Panel is initiating a 90-day comment period on a tentative amended final safety assessment for parabens, which the panel issued during its Dec. 12-13 meeting in Washington, D.C

Parabens Tentative Amended Final Report Issued By CIR

The Cosmetic Ingredient Review Expert Panel is initiating a 90-day comment period on a tentative amended final safety assessment for parabens, which the panel issued during its Dec. 12-13 meeting in Washington, D.C

CIR Requests Parabens Exposure Data, Reaffirms Phthalates Safety

The Cosmetic Ingredient Review Expert Panel is issuing an informal data request for quantitative estimates of exposure to parabens through certain consumer products, the panel announced during its Sept. 12-13 meeting in Washington, D.C

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel